Dyslipidemia in Patients with Lipodystrophy in the Use of Antiretroviral Therapy

QR Code

Dyslipidemia in Patients with Lipodystrophy in the Use of Antiretroviral Therapy

None

Saved in:

Bibliographic Details
Main Authors:	Libonati, Rosana, Dutra, Cláudia, Barbosa, Leonardo, Oliveira, Sandro, Lisbôa, Paulo, Libonati, Marcus
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27509
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.
by: Reneé de Waal, et al.
Published: (2013-01-01)

Gynoid Lipodystrophy Treatment and Other Advances on Laser-Assisted Liposuction
by: Goldman, Alberto, et al.
Published: (2011)

Simplification of Antiretroviral Therapy (ART)
by: Martinez, Maria Paloma Geijo
Published: (2011)

The impact of dermolipectomy in improving the quality of life in patients with abdominal lipodystrophy
by: Marilia de Pádua Dornelas Correa, et al.
Published: (2016-06-01)

Determinants of alignment level with public health risk management under COSO - ERM
by: Carla Janaína Ferreira Nobre Rêgo, et al.
Published: (2025-07-01)

Antiretroviral Therapy and HIV-Associated Neurocognitive Disorders
by: Akay, Cagla, et al.
Published: (2011)

Nutrigenetics and Dyslipidemia
by: Shalileh, Maryam
Published: (2012)

Methylphenidate and Dyslipidemia
by: Charach, Gideon, et al.
Published: (2012)

Surgical Pathology in HIV Infection in the Era of Antiretroviral Therapy
by: Romero-Guadarrama, Mónica Belinda
Published: (2011)

Highly Active Antiretroviral Therapy (HAART) and Metabolic Complications
by: Zha, Beth S., et al.
Published: (2011)

Clinical Relevance of Drug Interactions in HIV-Infected Patients Receiving Antiretroviral Therapy
by: Amariles, Pedro, et al.
Published: (2011)

Dyslipidemia and Cardiovascular Disease
by: Fakhrzadeh, Hossein, et al.
Published: (2012)

Dyslipidemia and Mental Illness
by: Saravane, D.
Published: (2012)

Dyslipidemia Induced by Stress
by: Marcondes, Fernanda Klein, et al.
Published: (2012)

Clinical Manifestations of HIV-Infection in the Era of Highly Active Antiretroviral Therapy
by: Guillén, Sara, et al.
Published: (2011)

HIV-associated lipodystrophy: epidemiological analysis of a Plastic Surgery Service in Brazil
by: Murilo Sgarbi Secanho, et al.
Published: (2023-05-01)

Effective polypill therapy in patients with hypertension and dyslipidemia
by: V. E. Oleynikov, et al.
Published: (2025-07-01)

Potential of combination therapy in patients with hypertension and dyslipidemia
by: T. V. Gorokhova, et al.
Published: (2022-08-01)

Dyslipidemia: Genetics and Role in the Metabolic Syndrome
by: Nock, Nora L., et al.
Published: (2012)

HIV/AIDS Associated Malignant Disorders: Role of Highly Active Antiretroviral Therapy
by: Mayor, Angel, et al.
Published: (2012)

Bioplastia na lipodistrofia de pacientes com HIV/AIDS Bioplasty for lipodystrophy in patients with HIV/AIDS
by: Marilho Tadeu Dornelas, et al.
Published: (2012-09-01)

Functions of OSBP/ORP Family Proteins and Their Relation to Dyslipidemia
by: Koriyama, Hiroshi, et al.
Published: (2012)

EFFECTS OF THERAPY ON THE ABILITY OF ERYTHROCYTES FLUVASTATIN AGGREGATION IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2012-03-01)

Impact of Climate Change and Air Pollution on Dyslipidemia and the Components of Metabolic Syndrome
by: Kelishadi, Roya, et al.
Published: (2012)

Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk Factors for Cardiovascular Disease
by: Pereira, Telmo
Published: (2012)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Psychological problems of HIV-infected patients in preparing to the start of antiretroviral therapy
by: O. V. Koltsova, et al.
Published: (2019-12-01)

Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS Patient
by: Erni J Nelwan
Published: (2014-10-01)

Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS Patient
by: Erni J Nelwan
Published: (2014-10-01)

Determination of HIV Tropism in Patients with Antiretroviral Therapy Failure in Arkhangelsk Region
by: Yu. V. Ostankova, et al.
Published: (2022-10-01)

Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women
by: Natalia Briceño-Patiño, et al.
Published: (2025-07-01)

Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
by: Ya. S. Ulyanova, et al.
Published: (2021-07-01)

The Role of Human Immunodeficiency Virus Type 1 (HIV-1) Proteins and Antiretroviral Drug Therapy in HIV-1-Induced Oxidative Stress
by: Reiche, Edna Maria Vissoci, et al.
Published: (2011)

Cases inefficient antiretroviral therapy for HIV-1 in children
by: Yu. V. Ostankova, et al.
Published: (2017-06-01)

DYSLIPIDEMIA FEATURES IN CHILDREN
by: T. I. Turkinа, et al.
Published: (2016-01-01)

Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
by: Huri, Hasniza Zaman
Published: (2012)

Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic
by: Yu. Sh. Gushchina, et al.
Published: (2023-07-01)

Cost analysis of the first line antiretroviral therapy in Russian Federation
by: A. V. Rudakova
Published: (2014-09-01)

Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
by: A. V. Kravchenko, et al.
Published: (2018-12-01)

Regulatory T-lymphocyte subsets in patients with HIV-infection receiving highly active antiretroviral therapy
by: V. A. Chereshnev, et al.
Published: (2019-05-01)